Figure 2From: Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study ATO and Ascorbic Acid induced gene expression modification of BAD in patients that reached stable disease or a response (major or minor). Back to article page